Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
Toxicon ; 108: 73-9, 2015 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-26435339

RESUMO

Senna occidentalis (S. occidentalis) is a toxic leguminous plant that contaminates crops and has been shown to be toxic to several animal species. All parts of the plant are toxic, but most of the plant's toxicity is due to its seeds. Despite its toxicity, S. occidentalis is widely used for therapeutic purposes in humans. The aim of the present work was to investigate, for the first time, the effects of the chronic administration of S. occidentalis seeds on hematopoietic organs, including the bone marrow and spleen. Fifty male Wistar rats were divided into five groups of 10 animals. Rats were treated with diets containing 0% (control), 0.5% (So0.5), 1% (So1), or 2% (So2) S. occidentalis seeds for a period of 90 days. Food and water were provided ad libitum, except to pair-fed (PF) group which received the same amount of ration to those of So2 group, however free of S. occidentalis seeds. It was verified that rats treated with 2% S. occidentalis seeds presented changes in hematological parameters. The blood evaluation also showed a significant decrease of the Myeloid/Erythroid (M/E) ratio. Chronic treatment with S. occidentalis promoted a reduction in the cellularity of both the bone marrow and spleen. Additionally, we observed changes in bone marrow smears, iron stores and spleen hemosiderin accumulation. Histological analyses of bone marrow revealed erythroid hyperplasia which was consistent with the increased reticulocyte count. These findings suggest that the long-term administration of S. occidentalis seeds can promote blood toxicity.


Assuntos
Medula Óssea/efeitos dos fármacos , Senna/toxicidade , Baço/efeitos dos fármacos , Toxinas Biológicas/toxicidade , Animais , Medula Óssea/patologia , Masculino , Ratos Wistar , Sementes/química , Sementes/toxicidade , Senna/química , Baço/patologia , Testes de Toxicidade Crônica
2.
Eur J Neurosci ; 32(1): 60-70, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-20608968

RESUMO

Huntington's disease is a neurodegenerative disorder caused by an expansion of CAGs repeats and characterized by alterations in mitochondrial functions. Although changes in Ca(2+) handling have been suggested, the mechanisms involved are not completely understood. The aim of this study was to investigate the possible alterations in Ca(2+) handling capacity and the relationship with mitochondrial dysfunction evaluated by NAD(P)H fluorescence, reactive oxygen species levels, mitochondrial membrane potential (DeltaPsi(m)) measurements and respiration in whole brain slices from R6/1 mice of different ages, evaluated in situ by real-time real-space microscopy. We show that the cortex and striatum of the 9-month-old R6/1 transgenic mice present a significant sustained increase in cytosolic Ca(2+) induced by glutamate (Glu). This difference in Glu response was partially reduced in R6/1 when in the absence of extracellular Ca(2+), indicating that N-methyl-D-aspartate receptors participation in this response is more important in transgenic mice. In addition, Glu also lead to a decrease in NAD(P)H fluorescence, a loss in DeltaPsi(m) and a further increase in respiration, which may have evoked a decrease in mitochondrial Ca(2+) Ca(2+)(m) uptake capacity. Taken together, these results show that alterations in Ca(2+) homeostasis in transgenic mice are associated with a decrease in Ca(2+)(m) uptake mechanism with a diminished Ca(2+) handling ability that ultimately causes dysfunctions and worsening of the neurodegenerative and the disease processes.


Assuntos
Encéfalo/metabolismo , Sinalização do Cálcio/fisiologia , Cálcio/metabolismo , Ácido Glutâmico/metabolismo , Mitocôndrias/metabolismo , Animais , Encéfalo/anatomia & histologia , Carbonil Cianeto p-Trifluormetoxifenil Hidrazona/metabolismo , Inibidores Enzimáticos/metabolismo , Homeostase , Humanos , Doença de Huntington/fisiopatologia , Masculino , Potencial da Membrana Mitocondrial/fisiologia , Camundongos , Camundongos Transgênicos , NADP/metabolismo , Consumo de Oxigênio/fisiologia , Espécies Reativas de Oxigênio/metabolismo , Tapsigargina/metabolismo , Desacopladores/metabolismo
3.
Neurosci Lett ; 442(2): 96-9, 2008 Sep 12.
Artigo em Inglês | MEDLINE | ID: mdl-18619521

RESUMO

Apoptosis is a natural cell elimination process involved in a number of physiological and pathological events. This process can be regulated by members of the Bcl-2 family. Bax, a pro-apoptotic member of this family, accelerates cell death, while the pro-survival member, Bcl-x(L), can antagonize the pro-apoptotic function of Bax to promote cell survival. In the present study, we have evaluated the effect of Bcl-x(L) on Bax-induced alterations in mitochondrial respiration and calcium release. We found that in primary cultured astrocytes, recombinant Bcl-x(L) is able to antagonize Bax-induced decrease in mitochondrial respiration and increase in mitochondrial calcium release. In addition, we found that Bcl-x(L) can lower the calcium store in the endoplasmic reticulum, thus limiting potential calcium flux induced by apoptosis. This regulation of calcium flux by Bcl-x(L) may represent an important mechanism by which this protein promotes cell survival.


Assuntos
Cálcio/metabolismo , Potencial da Membrana Mitocondrial/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Neurônios/ultraestrutura , Proteína X Associada a bcl-2/farmacologia , Proteína bcl-X/farmacologia , Trifosfato de Adenosina/farmacologia , Animais , Animais Recém-Nascidos , Células Cultivadas , Córtex Cerebral/citologia , Interações Medicamentosas , Inibidores Enzimáticos/farmacologia , Fura-2/metabolismo , Ionomicina/farmacologia , Ionóforos/farmacologia , Ratos , Tapsigargina/farmacologia , Fatores de Tempo
4.
Neurosci Lett ; 438(1): 59-63, 2008 Jun 13.
Artigo em Inglês | MEDLINE | ID: mdl-18468793

RESUMO

Huntington's disease (HD) is a hereditary dominant neurodegenerative disorder and the progression of the disease may be associated with apoptosis and altered expression of apoptotic proteins. The aim of this study was to investigate gene expression of bax and bcl-2 in tissues from R6/1 transgenic (TGN) mice of different ages (3, 6 and 9 months). The mRNA expression was investigated and related to apoptotic cells measured by TUNEL. Results showed a significant and progressive increase in bax levels in the cortex of TGN (from 10 to 33%) when compared to control (CT) (8 to 20%) mice with 3, 6 and 9-month-old. The increase in bax was correlated with the elevation in the number of apoptotic nuclei, especially in the cortex of 6 (10%) and 9 (18%)-month-old mice. Increase in bax expression might be related to an apoptotic induction which contributes to the HD progression.


Assuntos
Apoptose/genética , Predisposição Genética para Doença/genética , Doença de Huntington/genética , Doença de Huntington/metabolismo , Proteína X Associada a bcl-2/genética , Animais , Núcleo Celular/patologia , Córtex Cerebral/metabolismo , Córtex Cerebral/patologia , Córtex Cerebral/fisiopatologia , Progressão da Doença , Expressão Gênica/genética , Doença de Huntington/fisiopatologia , Marcação In Situ das Extremidades Cortadas , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos CBA , Camundongos Transgênicos , Degeneração Neural/genética , Degeneração Neural/metabolismo , Degeneração Neural/fisiopatologia , Neurônios/metabolismo , Neurônios/patologia , Proteínas Proto-Oncogênicas c-bcl-2/genética , RNA Mensageiro/metabolismo , Regulação para Cima/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...